Predominant expression of the long isoform of Bcl‐x (Bcl‐xL) in human lymphomas
- 1 March 1996
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 92 (4) , 900-906
- https://doi.org/10.1046/j.1365-2141.1996.423958.x
Abstract
Bcl‐x is a member of the bcl‐2 family of proteins which are characterized by their ability to modulate apoptosis. Alternative splicing results in two distinct bcl‐x mRNAs encoding a long isoform, bcl‐xL, which acts as a bcl‐2 agonist; and a short isoform, bcl‐xS, which inhibits bcl‐2 effects. The aim of the study was to determine whether bcl‐x is expressed in lymphoma tissues and to characterize the respective production of bcl‐xS and bcl‐xL. We investigated the expression of bcl‐x mRNA in a series of 50 non‐Hodgkin's lymphomas (NHL) and Hodgkin's disease (HD) cases using a RT‐PCR method in order to amplify both transcripts simultaneously, and to estimate their relative abundance. The rearrangements of the bcl‐2 gene were analysed by RT‐PCR expression of the hybrid bcl‐2–IgH mRNA. In addition, 20 PCR‐positive NHL cases and three HD cases were analysed by immunohistochemistry using bcl‐x polyclonal antisera. RT‐PCR showed bcl‐x expression in 43/45 NHLs and 5/5 HD cases. The bcl‐xL transcript was predominant in all positive cases and was associated with variable amounts of bcl‐xS. There was no significant correlation between the profile of bcl‐xL/bcl‐xS expression and the histological and immunological subtyping. Bcl‐x immunodetection was positive in the neoplastic cell component in all analysed cases, but the degree of staining was highly variable between cases. Expression of the hybrid bcl‐2–IgH gene was detected by RT‐PCR in five cases of follicular NHL and in one case of HD, but this group of tumours did not display a particular profile of bcl‐xL/bcl‐xS expression. We conclude that bcl‐x is commonly expressed by malignant cells in various types of malignant lymphomas, with a predominance of the bcl‐xL transcript. Since the corresponding bcl‐xL isoform can block the cell death machinery and potentialize bcl‐2 effects, it may be involved in some pathways of lymphomagenesis.Keywords
This publication has 0 references indexed in Scilit: